APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Glucose Dependent Insulinotropic Receptor

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Glucose Dependent Insulinotropic Receptor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173995640319 December 2025199 pages

Choose your research edition.

Industry ResearchGlucose Dependent Insulinotropic Receptor Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Glucose Dependent Insulinotropic Receptor Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Glucose Dependent Insulinotropic Receptor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Glucose Dependent Insulinotropic Receptor Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Glucose Dependent Insulinotropic Receptor Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Glucose Dependent Insulinotropic Receptor market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Glucose Dependent Insulinotropic Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Glucose Dependent Insulinotropic Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Glucose Dependent Insulinotropic Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Glucose Dependent Insulinotropic Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Glucose Dependent Insulinotropic Receptor include Takeda Pharmaceutical Co Ltd, Novartis AG, Merck & Co Inc, GlaxoSmithKline Plc, Amgen Inc, Yuhan Corp, Taisho Pharmaceutical Holdings Co Ltd, Kowa Co Ltd and Hyundai Pharmaceutical Co Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Glucose Dependent Insulinotropic Receptor market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Glucose Dependent Insulinotropic Receptor and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Glucose Dependent Insulinotropic Receptor revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Glucose Dependent Insulinotropic Receptor market size, projected growth trends, production technologies, key applications, and end-use industries.

Glucose Dependent Insulinotropic Receptor Segment by Company

Takeda Pharmaceutical Co Ltd

Novartis AG

Merck & Co Inc

GlaxoSmithKline Plc

Amgen Inc

Yuhan Corp

Taisho Pharmaceutical Holdings Co Ltd

Kowa Co Ltd

Hyundai Pharmaceutical Co Ltd

F. Hoffmann-La Roche Ltd

Dong-A Socio Holdings Co Ltd

CymaBay Therapeutics Inc

Arena Pharmaceuticals Inc

Glucose Dependent Insulinotropic Receptor Segment by Type

MBX-2982

HOB-047

HD-0471953

HD-0471042

GSK-2041706

DA-1241

Others

Glucose Dependent Insulinotropic Receptor Segment by Application

Type 2 Diabetes

Obesity

Chronic Obstructive Pulmonary Disease (COPD)

Dyslipidemia

Others

Glucose Dependent Insulinotropic Receptor Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glucose Dependent Insulinotropic Receptor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Glucose Dependent Insulinotropic Receptor and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glucose Dependent Insulinotropic Receptor.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Glucose Dependent Insulinotropic Receptor in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Glucose Dependent Insulinotropic Receptor industry.

Chapter 3: Detailed analysis of Glucose Dependent Insulinotropic Receptor companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Glucose Dependent Insulinotropic Receptorrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Glucose Dependent Insulinotropic Receptor Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of MBX-2982 Table 3. Key Players of HOB-047 Table 4. Key Players of HD-0471953 Table 3. Key Players of HD-0471042 Table 4. Key Players of GSK-2041706 Table 5. Key Players of DA-1241 Table 6. Key Players of Others Table 7. Global Glucose Dependent Insulinotropic Receptor Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 8. Key Players of Type 2 Diabetes Table 9. Key Players of Obesity Table 10. Key Players of Chronic Obstructive Pulmonary Disease (COPD) Table 11. Key Players of Dyslipidemia Table 12. Key Players of Others Table 13. Global Glucose Dependent Insulinotropic Receptor Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Glucose Dependent Insulinotropic Receptor Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Glucose Dependent Insulinotropic Receptor Market Share by Region (2021-2026) Table 16. Global Glucose Dependent Insulinotropic Receptor Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Glucose Dependent Insulinotropic Receptor Market Share by Region (2027-2032) Table 18. Glucose Dependent Insulinotropic Receptor Industry Trends Table 19. Glucose Dependent Insulinotropic Receptor Industry Drivers Table 20. Glucose Dependent Insulinotropic Receptor Industry Opportunities and Challenges Table 21. Glucose Dependent Insulinotropic Receptor Industry Restraints Table 22. Global Glucose Dependent Insulinotropic Receptor Revenue by Company (US$ Million) & (2021-2026) Table 23. Global Glucose Dependent Insulinotropic Receptor Revenue Market Share by Company (2021-2026) Table 24. Global Glucose Dependent Insulinotropic Receptor Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 25. Global Glucose Dependent Insulinotropic Receptor Key Company Head Office and Area Served Table 26. Global Glucose Dependent Insulinotropic Receptor Company, Product Type & Application Table 27. Global Glucose Dependent Insulinotropic Receptor Company Establishment Date Table 28. Global Company Market Concentration Ratio (CR5 and HHI) Table 29. Global Glucose Dependent Insulinotropic Receptor by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 30. Global Glucose Dependent Insulinotropic Receptor Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Glucose Dependent Insulinotropic Receptor Market Size by Type (2021-2026) & (US$ Million) Table 32. Global Glucose Dependent Insulinotropic Receptor Market Size by Type (2027-2032) & (US$ Million) Table 33. Global Glucose Dependent Insulinotropic Receptor Revenue Market Share by Type (2021-2026) Table 34. Global Glucose Dependent Insulinotropic Receptor Revenue Market Share by Type (2027-2032) Table 35. Global Glucose Dependent Insulinotropic Receptor Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Glucose Dependent Insulinotropic Receptor Market Size by Application (2021-2026) & (US$ Million) Table 37. Global Glucose Dependent Insulinotropic Receptor Market Size by Application (2027-2032) & (US$ Million) Table 38. Global Glucose Dependent Insulinotropic Receptor Revenue Market Share by Application (2021-2026) Table 39. Global Glucose Dependent Insulinotropic Receptor Revenue Market Share by Application (2027-2032) Table 40. Takeda Pharmaceutical Co Ltd Company Information Table 41. Takeda Pharmaceutical Co Ltd Business Overview Table 42. Takeda Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Takeda Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Product Portfolio Table 44. Takeda Pharmaceutical Co Ltd Recent Development Table 45. Novartis AG Company Information Table 46. Novartis AG Business Overview Table 47. Novartis AG Glucose Dependent Insulinotropic Receptor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Novartis AG Glucose Dependent Insulinotropic Receptor Product Portfolio Table 49. Novartis AG Recent Development Table 50. Merck & Co Inc Company Information Table 51. Merck & Co Inc Business Overview Table 52. Merck & Co Inc Glucose Dependent Insulinotropic Receptor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Merck & Co Inc Glucose Dependent Insulinotropic Receptor Product Portfolio Table 54. Merck & Co Inc Recent Development Table 55. GlaxoSmithKline Plc Company Information Table 56. GlaxoSmithKline Plc Business Overview Table 57. GlaxoSmithKline Plc Glucose Dependent Insulinotropic Receptor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. GlaxoSmithKline Plc Glucose Dependent Insulinotropic Receptor Product Portfolio Table 59. GlaxoSmithKline Plc Recent Development Table 60. Amgen Inc Company Information Table 61. Amgen Inc Business Overview Table 62. Amgen Inc Glucose Dependent Insulinotropic Receptor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Amgen Inc Glucose Dependent Insulinotropic Receptor Product Portfolio Table 64. Amgen Inc Recent Development Table 65. Yuhan Corp Company Information Table 66. Yuhan Corp Business Overview Table 67. Yuhan Corp Glucose Dependent Insulinotropic Receptor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Yuhan Corp Glucose Dependent Insulinotropic Receptor Product Portfolio Table 69. Yuhan Corp Recent Development Table 70. Taisho Pharmaceutical Holdings Co Ltd Company Information Table 71. Taisho Pharmaceutical Holdings Co Ltd Business Overview Table 72. Taisho Pharmaceutical Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Taisho Pharmaceutical Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Product Portfolio Table 74. Taisho Pharmaceutical Holdings Co Ltd Recent Development Table 75. Kowa Co Ltd Company Information Table 76. Kowa Co Ltd Business Overview Table 77. Kowa Co Ltd Glucose Dependent Insulinotropic Receptor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Kowa Co Ltd Glucose Dependent Insulinotropic Receptor Product Portfolio Table 79. Kowa Co Ltd Recent Development Table 80. Hyundai Pharmaceutical Co Ltd Company Information Table 81. Hyundai Pharmaceutical Co Ltd Business Overview Table 82. Hyundai Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Hyundai Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Product Portfolio Table 84. Hyundai Pharmaceutical Co Ltd Recent Development Table 85. F. Hoffmann-La Roche Ltd Company Information Table 86. F. Hoffmann-La Roche Ltd Business Overview Table 87. F. Hoffmann-La Roche Ltd Glucose Dependent Insulinotropic Receptor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. F. Hoffmann-La Roche Ltd Glucose Dependent Insulinotropic Receptor Product Portfolio Table 89. F. Hoffmann-La Roche Ltd Recent Development Table 90. Dong-A Socio Holdings Co Ltd Company Information Table 91. Dong-A Socio Holdings Co Ltd Business Overview Table 92. Dong-A Socio Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. Dong-A Socio Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Product Portfolio Table 94. Dong-A Socio Holdings Co Ltd Recent Development Table 95. CymaBay Therapeutics Inc Company Information Table 96. CymaBay Therapeutics Inc Business Overview Table 97. CymaBay Therapeutics Inc Glucose Dependent Insulinotropic Receptor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. CymaBay Therapeutics Inc Glucose Dependent Insulinotropic Receptor Product Portfolio Table 99. CymaBay Therapeutics Inc Recent Development Table 100. Arena Pharmaceuticals Inc Company Information Table 101. Arena Pharmaceuticals Inc Business Overview Table 102. Arena Pharmaceuticals Inc Glucose Dependent Insulinotropic Receptor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 103. Arena Pharmaceuticals Inc Glucose Dependent Insulinotropic Receptor Product Portfolio Table 104. Arena Pharmaceuticals Inc Recent Development Table 105. North America Glucose Dependent Insulinotropic Receptor Market Size by Type (2021-2026) & (US$ Million) Table 106. North America Glucose Dependent Insulinotropic Receptor Market Size by Type (2027-2032) & (US$ Million) Table 107. North America Glucose Dependent Insulinotropic Receptor Market Size by Application (2021-2026) & (US$ Million) Table 108. North America Glucose Dependent Insulinotropic Receptor Market Size by Application (2027-2032) & (US$ Million) Table 109. North America Glucose Dependent Insulinotropic Receptor Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. North America Glucose Dependent Insulinotropic Receptor Market Size by Country (2021-2026) Table 111. North America Glucose Dependent Insulinotropic Receptor Market Size by Country (2027-2032) Table 112. Europe Glucose Dependent Insulinotropic Receptor Market Size by Type (2021-2026) & (US$ Million) Table 113. Europe Glucose Dependent Insulinotropic Receptor Market Size by Type (2027-2032) & (US$ Million) Table 114. Europe Glucose Dependent Insulinotropic Receptor Market Size by Application (2021-2026) & (US$ Million) Table 115. Europe Glucose Dependent Insulinotropic Receptor Market Size by Application (2027-2032) & (US$ Million) Table 116. Europe Glucose Dependent Insulinotropic Receptor Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. Europe Glucose Dependent Insulinotropic Receptor Market Size by Country (2021-2026) Table 118. Europe Glucose Dependent Insulinotropic Receptor Market Size by Country (2027-2032) Table 119. China Glucose Dependent Insulinotropic Receptor Market Size by Type (2021-2026) & (US$ Million) Table 120. China Glucose Dependent Insulinotropic Receptor Market Size by Type (2027-2032) & (US$ Million) Table 121. China Glucose Dependent Insulinotropic Receptor Market Size by Application (2021-2026) & (US$ Million) Table 122. China Glucose Dependent Insulinotropic Receptor Market Size by Application (2027-2032) & (US$ Million) Table 123. Asia Glucose Dependent Insulinotropic Receptor Market Size by Type (2021-2026) & (US$ Million) Table 124. Asia Glucose Dependent Insulinotropic Receptor Market Size by Type (2027-2032) & (US$ Million) Table 125. Asia Glucose Dependent Insulinotropic Receptor Market Size by Application (2021-2026) & (US$ Million) Table 126. Asia Glucose Dependent Insulinotropic Receptor Market Size by Application (2027-2032) & (US$ Million) Table 127. Asia Glucose Dependent Insulinotropic Receptor Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 128. Asia Glucose Dependent Insulinotropic Receptor Market Size by Country (2021-2026) Table 129. Asia Glucose Dependent Insulinotropic Receptor Market Size by Country (2027-2032) Table 130. South America, Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Size by Type (2021-2026) & (US$ Million) Table 131. South America, Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Size by Type (2027-2032) & (US$ Million) Table 132. South America, Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Size by Application (2021-2026) & (US$ Million) Table 133. South America, Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Size by Application (2027-2032) & (US$ Million) Table 134. South America, Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. South America, Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Size by Country (2021-2026) Table 136. South America, Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Size by Country (2027-2032) Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. Glucose Dependent Insulinotropic Receptor Product Image Figure 2. Global Glucose Dependent Insulinotropic Receptor Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Glucose Dependent Insulinotropic Receptor Market Share by Type: 2025 VS 2032 Figure 4. MBX-2982 Image Figure 5. HOB-047 Image Figure 6. HD-0471953 Image Figure 7. HD-0471042 Image Figure 8. GSK-2041706 Image Figure 9. DA-1241 Image Figure 10. Others Image Figure 11. Global Glucose Dependent Insulinotropic Receptor Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 12. Global Glucose Dependent Insulinotropic Receptor Market Share by Application: 2025 VS 2032 Figure 13. Type 2 Diabetes Image Figure 14. Obesity Image Figure 15. Chronic Obstructive Pulmonary Disease (COPD) Image Figure 16. Dyslipidemia Image Figure 17. Others Image Figure 18. Global Glucose Dependent Insulinotropic Receptor Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 19. Global Glucose Dependent Insulinotropic Receptor Market Size (2021-2032) & (US$ Million) Figure 20. Global Glucose Dependent Insulinotropic Receptor Market Share by Region: 2025 VS 2032 Figure 21. Years Considered Figure 22. Global Glucose Dependent Insulinotropic Receptor Market Share by Players in 2025 Figure 23. Global Top 5 and 10 Glucose Dependent Insulinotropic Receptor Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Global Glucose Dependent Insulinotropic Receptor Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Glucose Dependent Insulinotropic Receptor Revenue Market Share by Type (2021-2032) Figure 27. Global Glucose Dependent Insulinotropic Receptor Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Glucose Dependent Insulinotropic Receptor Revenue Market Share by Application (2021-2032) Figure 29. North America Glucose Dependent Insulinotropic Receptor Market Size (2021-2032) & (US$ Million) Figure 30. North America Glucose Dependent Insulinotropic Receptor Market Share by Type (2021-2032) Figure 31. North America Glucose Dependent Insulinotropic Receptor Market Share by Application (2021-2032) Figure 32. North America Glucose Dependent Insulinotropic Receptor Market Share by Country (2021-2032) Figure 33. United States Glucose Dependent Insulinotropic Receptor Market Size (2021-2032) & (US$ Million) Figure 34. Canada Glucose Dependent Insulinotropic Receptor Market Size (2021-2032) & (US$ Million) Figure 35. Mexico Glucose Dependent Insulinotropic Receptor Market Size (2021-2032) & (US$ Million) Figure 36. Europe Glucose Dependent Insulinotropic Receptor Market Size (2021-2032) & (US$ Million) Figure 37. Europe Glucose Dependent Insulinotropic Receptor Market Share by Type (2021-2032) Figure 38. Europe Glucose Dependent Insulinotropic Receptor Market Share by Application (2021-2032) Figure 39. Europe Glucose Dependent Insulinotropic Receptor Market Share by Country (2021-2032) Figure 40. Germany Glucose Dependent Insulinotropic Receptor Market Size (2021-2032) & (US$ Million) Figure 41. France Glucose Dependent Insulinotropic Receptor Market Size (2021-2032) & (US$ Million) Figure 42. U.K. Glucose Dependent Insulinotropic Receptor Market Size (2021-2032) & (US$ Million) Figure 43. Italy Glucose Dependent Insulinotropic Receptor Market Size (2021-2032) & (US$ Million) Figure 44. Russia Glucose Dependent Insulinotropic Receptor Market Size (2021-2032) & (US$ Million) Figure 45. Nordic Countries Glucose Dependent Insulinotropic Receptor Market Size (2021-2032) & (US$ Million) Figure 46. China Glucose Dependent Insulinotropic Receptor Market Size (2021-2032) & (US$ Million) Figure 47. China Glucose Dependent Insulinotropic Receptor Market Share by Type (2021-2032) Figure 48. China Glucose Dependent Insulinotropic Receptor Market Share by Application (2021-2032) Figure 49. Asia Glucose Dependent Insulinotropic Receptor Market Size (2021-2032) & (US$ Million) Figure 50. Asia Glucose Dependent Insulinotropic Receptor Market Share by Type (2021-2032) Figure 51. Asia Glucose Dependent Insulinotropic Receptor Market Share by Application (2021-2032) Figure 52. Asia Glucose Dependent Insulinotropic Receptor Market Share by Country (2021-2032) Figure 53. Japan Glucose Dependent Insulinotropic Receptor Market Size (2021-2032) & (US$ Million) Figure 54. South Korea Glucose Dependent Insulinotropic Receptor Market Size (2021-2032) & (US$ Million) Figure 55. Taiwan Glucose Dependent Insulinotropic Receptor Market Size (2021-2032) & (US$ Million) Figure 56. Southeast Asia Glucose Dependent Insulinotropic Receptor Market Size (2021-2032) & (US$ Million) Figure 57. India Glucose Dependent Insulinotropic Receptor Market Size (2021-2032) & (US$ Million) Figure 58. Australia Glucose Dependent Insulinotropic Receptor Market Size (2021-2032) & (US$ Million) Figure 59. South America, Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Size (2021-2032) & (US$ Million) Figure 60. South America, Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Share by Type (2021-2032) Figure 61. South America, Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Share by Application (2021-2032) Figure 62. South America, Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Share by Country (2021-2032) Figure 63. Brazil Glucose Dependent Insulinotropic Receptor Market Size (2021-2032) & (US$ Million) Figure 64. South Africa Glucose Dependent Insulinotropic Receptor Market Size (2021-2032) & (US$ Million) Figure 65. Saudi Arabia Glucose Dependent Insulinotropic Receptor Market Size (2021-2032) & (US$ Million) Figure 66. Turkey Glucose Dependent Insulinotropic Receptor Market Size (2021-2032) & (US$ Million) Figure 67. Argentina Glucose Dependent Insulinotropic Receptor Market Size (2021-2032) & (US$ Million) Figure 68. UAE Glucose Dependent Insulinotropic Receptor Market Size (2021-2032) & (US$ Million) Figure 69. Egypt Glucose Dependent Insulinotropic Receptor Market Size (2021-2032) & (US$ Million) Figure 70. Chile Glucose Dependent Insulinotropic Receptor Market Size (2021-2032) & (US$ Million) Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • MBX-2982
  • HOB-047
  • HD-0471953
  • HD-0471042
  • GSK-2041706
  • DA-1241
  • Others
Applications
  • Type 2 Diabetes
  • Obesity
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Dyslipidemia
  • Others
Companies covered
  • Takeda Pharmaceutical Co Ltd
  • Novartis AG
  • Merck & Co Inc
  • GlaxoSmithKline Plc
  • Amgen Inc
  • Yuhan Corp
  • Taisho Pharmaceutical Holdings Co Ltd
  • Kowa Co Ltd
  • Hyundai Pharmaceutical Co Ltd
  • F. Hoffmann-La Roche Ltd
  • Dong-A Socio Holdings Co Ltd
  • CymaBay Therapeutics Inc
  • Arena Pharmaceuticals Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Glucose Dependent Insulinotropic Receptor Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 MBX-2982
  5. 1.2.3 HOB-047
  6. 1.2.4 HD-0471953
  7. 1.2.5 HD-0471042
  8. 1.2.6 GSK-2041706
  9. 1.2.7 DA-1241
  10. 1.2.8 Others
  11. 1.3 Market Analysis by Application
  12. 1.3.1 Global Glucose Dependent Insulinotropic Receptor Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  13. 1.3.2 Type 2 Diabetes
  14. 1.3.3 Obesity
  15. 1.3.4 Chronic Obstructive Pulmonary Disease (COPD)
  16. 1.3.5 Dyslipidemia
  17. 1.3.6 Others
  18. 1.4 Global Market Growth Prospects
  19. 1.5 Global Glucose Dependent Insulinotropic Receptor Growth Trends by Region
  20. 1.5.1 Global Glucose Dependent Insulinotropic Receptor Market Size by Region: 2021 VS 2025 VS 2032
  21. 1.5.2 Glucose Dependent Insulinotropic Receptor Market Size by Region (2021-2026)
  22. 1.5.3 Glucose Dependent Insulinotropic Receptor Market Size by Region (2027-2032)
  23. 1.6 Assumptions and Limitations
  24. 1.7 Study Goals and Objectives
  25. 1.8 Years Considered
2 Global Glucose Dependent Insulinotropic Receptor Market Dynamics
  1. 2.1 Glucose Dependent Insulinotropic Receptor Industry Trends
  2. 2.2 Glucose Dependent Insulinotropic Receptor Industry Drivers
  3. 2.3 Glucose Dependent Insulinotropic Receptor Industry Opportunities and Challenges
  4. 2.4 Glucose Dependent Insulinotropic Receptor Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Glucose Dependent Insulinotropic Receptor Revenue by Company (2021-2026)
  2. 3.2 Global Glucose Dependent Insulinotropic Receptor Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Glucose Dependent Insulinotropic Receptor Key Company Head office and Area Served
  4. 3.4 Global Glucose Dependent Insulinotropic Receptor Company, Product Type & Application
  5. 3.5 Global Glucose Dependent Insulinotropic Receptor Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Glucose Dependent Insulinotropic Receptor Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Glucose Dependent Insulinotropic Receptor Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Glucose Dependent Insulinotropic Receptor Tier 1, Tier 2, and Tier 3
4 Glucose Dependent Insulinotropic Receptor Market by Type
  1. 4.1 Global Glucose Dependent Insulinotropic Receptor Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Glucose Dependent Insulinotropic Receptor Market Size by Type (2021-2032)
  3. 4.3 Global Glucose Dependent Insulinotropic Receptor Market Size Share by Type (2021-2032)
5 Glucose Dependent Insulinotropic Receptor Market by Application
  1. 5.1 Global Glucose Dependent Insulinotropic Receptor Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Glucose Dependent Insulinotropic Receptor Market Size by Application (2021-2032)
  3. 5.3 Global Glucose Dependent Insulinotropic Receptor Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Takeda Pharmaceutical Co Ltd
  2. 6.1.1 Takeda Pharmaceutical Co Ltd Company Information
  3. 6.1.2 Takeda Pharmaceutical Co Ltd Business Overview
  4. 6.1.3 Takeda Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Takeda Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Product Portfolio
  6. 6.1.5 Takeda Pharmaceutical Co Ltd Recent Developments
  7. 6.2 Novartis AG
  8. 6.2.1 Novartis AG Company Information
  9. 6.2.2 Novartis AG Business Overview
  10. 6.2.3 Novartis AG Glucose Dependent Insulinotropic Receptor Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Novartis AG Glucose Dependent Insulinotropic Receptor Product Portfolio
  12. 6.2.5 Novartis AG Recent Developments
  13. 6.3 Merck & Co Inc
  14. 6.3.1 Merck & Co Inc Company Information
  15. 6.3.2 Merck & Co Inc Business Overview
  16. 6.3.3 Merck & Co Inc Glucose Dependent Insulinotropic Receptor Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Merck & Co Inc Glucose Dependent Insulinotropic Receptor Product Portfolio
  18. 6.3.5 Merck & Co Inc Recent Developments
  19. 6.4 GlaxoSmithKline Plc
  20. 6.4.1 GlaxoSmithKline Plc Company Information
  21. 6.4.2 GlaxoSmithKline Plc Business Overview
  22. 6.4.3 GlaxoSmithKline Plc Glucose Dependent Insulinotropic Receptor Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 GlaxoSmithKline Plc Glucose Dependent Insulinotropic Receptor Product Portfolio
  24. 6.4.5 GlaxoSmithKline Plc Recent Developments
  25. 6.5 Amgen Inc
  26. 6.5.1 Amgen Inc Company Information
  27. 6.5.2 Amgen Inc Business Overview
  28. 6.5.3 Amgen Inc Glucose Dependent Insulinotropic Receptor Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Amgen Inc Glucose Dependent Insulinotropic Receptor Product Portfolio
  30. 6.5.5 Amgen Inc Recent Developments
  31. 6.6 Yuhan Corp
  32. 6.6.1 Yuhan Corp Company Information
  33. 6.6.2 Yuhan Corp Business Overview
  34. 6.6.3 Yuhan Corp Glucose Dependent Insulinotropic Receptor Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Yuhan Corp Glucose Dependent Insulinotropic Receptor Product Portfolio
  36. 6.6.5 Yuhan Corp Recent Developments
  37. 6.7 Taisho Pharmaceutical Holdings Co Ltd
  38. 6.7.1 Taisho Pharmaceutical Holdings Co Ltd Company Information
  39. 6.7.2 Taisho Pharmaceutical Holdings Co Ltd Business Overview
  40. 6.7.3 Taisho Pharmaceutical Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Taisho Pharmaceutical Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Product Portfolio
  42. 6.7.5 Taisho Pharmaceutical Holdings Co Ltd Recent Developments
  43. 6.8 Kowa Co Ltd
  44. 6.8.1 Kowa Co Ltd Company Information
  45. 6.8.2 Kowa Co Ltd Business Overview
  46. 6.8.3 Kowa Co Ltd Glucose Dependent Insulinotropic Receptor Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Kowa Co Ltd Glucose Dependent Insulinotropic Receptor Product Portfolio
  48. 6.8.5 Kowa Co Ltd Recent Developments
  49. 6.9 Hyundai Pharmaceutical Co Ltd
  50. 6.9.1 Hyundai Pharmaceutical Co Ltd Company Information
  51. 6.9.2 Hyundai Pharmaceutical Co Ltd Business Overview
  52. 6.9.3 Hyundai Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Hyundai Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Product Portfolio
  54. 6.9.5 Hyundai Pharmaceutical Co Ltd Recent Developments
  55. 6.10 F. Hoffmann-La Roche Ltd
  56. 6.10.1 F. Hoffmann-La Roche Ltd Company Information
  57. 6.10.2 F. Hoffmann-La Roche Ltd Business Overview
  58. 6.10.3 F. Hoffmann-La Roche Ltd Glucose Dependent Insulinotropic Receptor Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 F. Hoffmann-La Roche Ltd Glucose Dependent Insulinotropic Receptor Product Portfolio
  60. 6.10.5 F. Hoffmann-La Roche Ltd Recent Developments
  61. 6.11 Dong-A Socio Holdings Co Ltd
  62. 6.11.1 Dong-A Socio Holdings Co Ltd Company Information
  63. 6.11.2 Dong-A Socio Holdings Co Ltd Business Overview
  64. 6.11.3 Dong-A Socio Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Dong-A Socio Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Product Portfolio
  66. 6.11.5 Dong-A Socio Holdings Co Ltd Recent Developments
  67. 6.12 CymaBay Therapeutics Inc
  68. 6.12.1 CymaBay Therapeutics Inc Company Information
  69. 6.12.2 CymaBay Therapeutics Inc Business Overview
  70. 6.12.3 CymaBay Therapeutics Inc Glucose Dependent Insulinotropic Receptor Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 CymaBay Therapeutics Inc Glucose Dependent Insulinotropic Receptor Product Portfolio
  72. 6.12.5 CymaBay Therapeutics Inc Recent Developments
  73. 6.13 Arena Pharmaceuticals Inc
  74. 6.13.1 Arena Pharmaceuticals Inc Company Information
  75. 6.13.2 Arena Pharmaceuticals Inc Business Overview
  76. 6.13.3 Arena Pharmaceuticals Inc Glucose Dependent Insulinotropic Receptor Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Arena Pharmaceuticals Inc Glucose Dependent Insulinotropic Receptor Product Portfolio
  78. 6.13.5 Arena Pharmaceuticals Inc Recent Developments
7 North America
  1. 7.1 North America Glucose Dependent Insulinotropic Receptor Market Size (2021-2032)
  2. 7.2 North America Glucose Dependent Insulinotropic Receptor Market Size by Type
  3. 7.2.1 North America Glucose Dependent Insulinotropic Receptor Market Size by Type (2021-2026)
  4. 7.2.2 North America Glucose Dependent Insulinotropic Receptor Market Size by Type (2027-2032)
  5. 7.2.3 North America Glucose Dependent Insulinotropic Receptor Market Share by Type (2021-2032)
  6. 7.3 North America Glucose Dependent Insulinotropic Receptor Market Size by Application
  7. 7.3.1 North America Glucose Dependent Insulinotropic Receptor Market Size by Application (2021-2026)
  8. 7.3.2 North America Glucose Dependent Insulinotropic Receptor Market Size by Application (2027-2032)
  9. 7.3.3 North America Glucose Dependent Insulinotropic Receptor Market Share by Application (2021-2032)
  10. 7.4 North America Glucose Dependent Insulinotropic Receptor Market Size by Country
  11. 7.4.1 North America Glucose Dependent Insulinotropic Receptor Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Glucose Dependent Insulinotropic Receptor Market Size by Country (2021-2026)
  13. 7.4.3 North America Glucose Dependent Insulinotropic Receptor Market Size by Country (2027-2032)
  14. 7.4.4 North America Glucose Dependent Insulinotropic Receptor Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Glucose Dependent Insulinotropic Receptor Market Size (2021-2032)
  2. 8.2 Europe Glucose Dependent Insulinotropic Receptor Market Size by Type
  3. 8.2.1 Europe Glucose Dependent Insulinotropic Receptor Market Size by Type (2021-2026)
  4. 8.2.2 Europe Glucose Dependent Insulinotropic Receptor Market Size by Type (2027-2032)
  5. 8.2.3 Europe Glucose Dependent Insulinotropic Receptor Market Share by Type (2021-2032)
  6. 8.3 Europe Glucose Dependent Insulinotropic Receptor Market Size by Application
  7. 8.3.1 Europe Glucose Dependent Insulinotropic Receptor Market Size by Application (2021-2026)
  8. 8.3.2 Europe Glucose Dependent Insulinotropic Receptor Market Size by Application (2027-2032)
  9. 8.3.3 Europe Glucose Dependent Insulinotropic Receptor Market Share by Application (2021-2032)
  10. 8.4 Europe Glucose Dependent Insulinotropic Receptor Market Size by Country
  11. 8.4.1 Europe Glucose Dependent Insulinotropic Receptor Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Glucose Dependent Insulinotropic Receptor Market Size by Country (2021-2026)
  13. 8.4.3 Europe Glucose Dependent Insulinotropic Receptor Market Size by Country (2027-2032)
  14. 8.4.4 Europe Glucose Dependent Insulinotropic Receptor Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Glucose Dependent Insulinotropic Receptor Market Size (2021-2032)
  2. 9.2 China Glucose Dependent Insulinotropic Receptor Market Size by Type
  3. 9.2.1 China Glucose Dependent Insulinotropic Receptor Market Size by Type (2021-2026)
  4. 9.2.2 China Glucose Dependent Insulinotropic Receptor Market Size by Type (2027-2032)
  5. 9.2.3 China Glucose Dependent Insulinotropic Receptor Market Share by Type (2021-2032)
  6. 9.3 China Glucose Dependent Insulinotropic Receptor Market Size by Application
  7. 9.3.1 China Glucose Dependent Insulinotropic Receptor Market Size by Application (2021-2026)
  8. 9.3.2 China Glucose Dependent Insulinotropic Receptor Market Size by Application (2027-2032)
  9. 9.3.3 China Glucose Dependent Insulinotropic Receptor Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Glucose Dependent Insulinotropic Receptor Market Size (2021-2032)
  2. 10.2 Asia Glucose Dependent Insulinotropic Receptor Market Size by Type
  3. 10.2.1 Asia Glucose Dependent Insulinotropic Receptor Market Size by Type (2021-2026)
  4. 10.2.2 Asia Glucose Dependent Insulinotropic Receptor Market Size by Type (2027-2032)
  5. 10.2.3 Asia Glucose Dependent Insulinotropic Receptor Market Share by Type (2021-2032)
  6. 10.3 Asia Glucose Dependent Insulinotropic Receptor Market Size by Application
  7. 10.3.1 Asia Glucose Dependent Insulinotropic Receptor Market Size by Application (2021-2026)
  8. 10.3.2 Asia Glucose Dependent Insulinotropic Receptor Market Size by Application (2027-2032)
  9. 10.3.3 Asia Glucose Dependent Insulinotropic Receptor Market Share by Application (2021-2032)
  10. 10.4 Asia Glucose Dependent Insulinotropic Receptor Market Size by Country
  11. 10.4.1 Asia Glucose Dependent Insulinotropic Receptor Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Glucose Dependent Insulinotropic Receptor Market Size by Country (2021-2026)
  13. 10.4.3 Asia Glucose Dependent Insulinotropic Receptor Market Size by Country (2027-2032)
  14. 10.4.4 Asia Glucose Dependent Insulinotropic Receptor Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Glucose Dependent Insulinotropic Receptor Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst